Rheumatic Heart Disease Burden in Africa and the Need to Build Robust Infrastructure.

Area of Science:

• Cardiology
• Epidemiology
• Public Health

Background:

• Rheumatic heart disease (RHD) is a critical public health issue in Africa.
• Prevalence varies significantly across the continent, influenced by healthcare access, poverty, and genetics.

Purpose of the Study:

• To map the epidemiology of RHD in Africa, including geographic distribution, temporal trends, and demographics.
• To explore challenges and opportunities in RHD diagnosis, biomarkers, and prevention.

Main Methods:

• Review of existing epidemiological data on RHD in Africa.
• Analysis of factors contributing to RHD burden, including Group A Streptococcus (GAS) incidence.
• Exploration of diagnostic tools and vaccine development for RHD.

Main Results:

• RHD prevalence ranges from 2.9 to 30.4 per 1,000 population, with higher rates in females and children.
• Limited healthcare access, poverty, and lack of research hinder RHD control.
• Diagnostic challenges include inaccessibility of facilities and personnel; promising biomarkers require validation.

Conclusions:

• Addressing RHD in Africa necessitates robust biomarkers, accessible diagnostics, and effective GAS vaccines.
• Targeted interventions are crucial, especially for high-prevalence groups.
• Further research and resource allocation are vital for RHD control and management.